iNKT cells as key mediators of inflammation - Dissecting the role played by iNKT cells in haematopoiesis. (360G-Wellcome-086322_Z_08_A)

£23,687

The overall aim of this research programme is to investigate the role played by invariant NKT cells in myelopoiesis; in influencing the differentiation of cells along the myeloid lineage, key players in inflammation. Research will be divided into three complementing programmes: Objective 1: Identification of leukocyte populations which require iNKT cells for differentiation Objective 2: Test the hypothesis that iNKT cells enhance the speed of haematologic recovery Objective 3: Dissect the molecular mechanisms of iNKT cell-mediated MDSC differentiation Significance: iNKT cells are at the interface between the innate and adaptive immune responses. Understanding the mechanisms by which iNKT cells modulate haematopoiesis and inflammation will be of importance to develop strategies to stimulate myelopoesis and harness iNKT cell activation during inflammation.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 23687
Applicant Surname Yip
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2010-01-18T00:00:00+00:00
Financial Year 2009/10
Grant Programme: Title PhD Studentship (Basic)
Internal ID 086322/Z/08/A
Lead Applicant Mr Ronald Yip
Partnership Value 23687
Planned Dates: End Date 2012-09-30T00:00:00+00:00
Planned Dates: Start Date 2010-02-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South East
Sponsor(s) Prof Keith Gull